Passage Bio, Inc.
PASG
$7.48
-$0.065-0.86%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 39.08% | -21.06% | 34.20% | -20.94% | 4.31% |
| Total Depreciation and Amortization | -15.92% | -72.04% | -5.27% | -4.77% | -1.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -74.14% | -60.21% | 57.74% | 235.89% | 49.35% |
| Change in Net Operating Assets | 185.97% | 59.12% | -203.47% | 1,481.12% | 108.12% |
| Cash from Operations | 54.29% | -63.99% | -13.39% | 43.31% | 30.60% |
| Capital Expenditure | -- | -- | 30.00% | -- | -- |
| Sale of Property, Plant, and Equipment | 0.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 185.17% | -8.65% | 1,330.25% | -95.85% |
| Cash from Investing | -98.52% | 189.74% | -8.62% | 1,328.34% | -95.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -99.03% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -100.00% | -99.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -122.23% | 388.24% | -29.79% | 162.67% | -179.68% |